2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Oz Rey LLC | — | 1,100,000 | Feb 14, 2020 |
| MV Amanth LLC | — | 1,100,000 | Feb 14, 2020 |
| Hersch Robert Sumner | — | 1,100,000 | Feb 14, 2020 |
| Hooters Of Washington, L.L.C. | — | 680,272 | Feb 10, 2014 |
| Hooters Of Oregon Partners, L.L.C. | — | 680,272 | Feb 10, 2014 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Dec 4, 2025 | Kenney Richard T | Chief Medical Officer | Neutral | 27.5 | -259,639 | -78.86% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | MCANDREW STEPHEN J | Chief Business Officer | Neutral | 27.5 | -6,446 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Griffith Donald J. | CFO | Neutral | 27.5 | -10,375 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | McNeill Lori | Director | Neutral | 27.5 | -4,394 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Dexter Susan | Director | Neutral | 27.5 | -9,643 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Rao Raghu | CEO | Neutral | 27.5 | -22,356 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Cini John K. | Director | Neutral | 27.5 | -14,116 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Bhatt Nailesh | Director | Neutral | 27.5 | -10,547 | -100.00% | ✗ | - |
| Dec 2, 2025 | Dec 3, 2025 | Dyrness Albert D. | Director | Neutral | 27.5 | -4,537 | -100.00% | ✗ | - |
| Jun 30, 2025 | Aug 21, 2025 | Kenney Richard T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 11, 2023 | Jul 15, 2025 | Dyrness Albert D. | Director | Neutral | 90.0 | +4,000 | 744.88% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | MCANDREW STEPHEN J | Chief Business Officer | Neutral | 90.0 | +6,000 | 1345.29% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Rao Raghu | CEO | Neutral | 90.0 | +20,000 | 848.90% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Griffith Donald J. | CFO | Neutral | 90.0 | +10,000 | 2666.67% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | McNeill Lori | Director | Neutral | 90.0 | +4,000 | 1015.23% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Bhatt Nailesh | Director | Neutral | 90.0 | +10,000 | 1828.15% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Kenney Richard T | Chief Medical Officer | Neutral | 90.0 | +8,000 | 582.24% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Cini John K. | Chief Scientific Officer | Neutral | 90.0 | +12,000 | 567.11% | ✗ | - |
| Jul 11, 2025 | Jul 15, 2025 | Dexter Susan | Chief Technical Officer | Neutral | 90.0 | +8,000 | 486.91% | ✗ | - |
| Feb 21, 2025 | MCANDREW STEPHEN J | Chief Business Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 11, 2023 | Dec 5, 2024 | Bhatt Nailesh | Director | Neutral | 90.0 | +373 | 214.37% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Dexter Susan | Chief Technical Officer | Neutral | 90.0 | +1,452 | 760.21% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | McNeill Lori | Director | Neutral | 90.0 | +373 | 1776.19% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Dyrness Albert D. | Director | Neutral | 90.0 | +373 | 227.44% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Rao Raghu | Director | Neutral | 90.0 | +373 | 18.81% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Cini John K. | Chief Scientific Officer | Neutral | 90.0 | +1,888 | 828.07% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Griffith Donald J. | Director | Neutral | 90.0 | +317 | 546.55% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Mohan Pankaj | CEO | Neutral | 90.0 | +7,554 | 96.69% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Kenney Richard T | Chief Medical Officer | Neutral | 90.0 | +1,271 | 1233.98% | ✗ | - |
| Dec 11, 2023 | Dec 5, 2024 | Cross John Harry III | CFO | Neutral | 27.5 | -1,452 | -47.76% | ✗ | - |
| Oct 27, 2023 | Oct 27, 2023 | Rao Raghu | Director | Neutral | 90.0 | +15,625 | 1315.24% | ✗ | - |
| Oct 27, 2023 | Oct 27, 2023 | Mohan Pankaj | CEO | Neutral | 90.0 | +34,375 | 121.91% | ✗ | - |
| Sep 7, 2023 | Markey John | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 14, 2023 | Jun 15, 2023 | Dexter Susan | Chief Technical Officer | Buy | 90.0 | +10,000 | 42.25% | ✗ | $7K |
| May 30, 2023 | May 31, 2023 | Dyrness Albert D. | Director | Buy | 91.3 | +23,255 | 407.48% | ✗ | $10.9K |
| May 17, 2023 | May 18, 2023 | Bhatt Nailesh | Director | Buy | 90.0 | +25,000 | 436.07% | ✗ | $5.8K |
| May 15, 2023 | May 15, 2023 | Mohan Pankaj | CEO | Buy | 95.0 | +371,600 | 149.37% | ✗ | $82.9K |
| Mar 15, 2023 | Mar 16, 2023 | Mohan Pankaj | CEO | Buy | 91.3 | +60,000 | 31.78% | ✗ | $35.1K |
| Jan 7, 2023 | Feb 17, 2023 | Mohan Pankaj | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2023 | Feb 17, 2023 | Dexter Susan | Chief Technical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2023 | Feb 17, 2023 | Kenney Richard T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 7, 2023 | Feb 17, 2023 | Cini John K. | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 6, 2023 | Feb 17, 2023 | Cross John Harry III | CFO | Sell | 27.5 | -1,960 | -7.57% | ✗ | $2.1K |
| Dec 9, 2022 | Feb 17, 2023 | Griffith Donald J. | Director | Sell | 90.0 | +2,717 | 35.83% | ✗ | $518.4 |
| Dec 14, 2022 | Dec 22, 2022 | Rao Raghu | Director | Neutral | 90.0 | +3,770 | 16.85% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Dexter Susan | Chief Technical Officer | Neutral | 90.0 | +14,627 | 11.56% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Mohan Pankaj | CEO | Neutral | 82.5 | +74,205 | 4.60% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Cross John Harry III | CFO | Neutral | 90.0 | +15,519 | 10.69% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Cini John K. | Chief Scientific Officer | Neutral | 85.0 | +18,551 | 6.10% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Bhatt Nailesh | Director | Neutral | 90.0 | +3,770 | 13.72% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | McNeill Lori | Director | Neutral | 90.0 | +3,770 | 100.00% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Kenney Richard T | Chief Medical Officer | Neutral | 90.0 | +14,627 | 29.25% | ✗ | - |
| Dec 14, 2022 | Dec 22, 2022 | Dyrness Albert D. | Director | Neutral | 90.0 | +3,770 | 13.90% | ✗ | - |
| Oct 4, 2022 | McNeill Lori | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 15, 2021 | Apr 8, 2022 | Dexter Susan | Chief Technical Officer | Neutral | 90.0 | +63,104 | 99.43% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Griffith Donald J. | Director | Sell | 90.0 | +10,493 | 10.97% | ✗ | $1.7K |
| Dec 15, 2021 | Apr 8, 2022 | Rao Raghu | Director | Neutral | 90.0 | +14,152 | 172.21% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Cini John K. | Chief Scientific Officer | Neutral | 90.0 | +80,034 | 35.72% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Mohan Pankaj | CEO | Neutral | 90.0 | +320,135 | 24.76% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Cross John Harry III | CFO | Neutral | 90.0 | +66,951 | 85.60% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Dyrness Albert D. | Director | Neutral | 90.0 | +14,152 | 109.10% | ✗ | - |
| Dec 15, 2021 | Apr 8, 2022 | Bhatt Nailesh | Director | Neutral | 90.0 | +14,152 | 106.14% | ✗ | - |
| Jun 9, 2021 | Jun 9, 2021 | Kenney Richard T | Chief Medical Officer | Buy | 91.3 | +15,000 | 42.86% | ✗ | $23.1K |
| Jun 9, 2021 | Jun 9, 2021 | Mohan Pankaj | CEO | Buy | 83.8 | +32,000 | 2.54% | ✗ | $49.6K |
| May 25, 2021 | May 28, 2021 | Cini John K. | Chief Scientific Officer | Sell | 26.3 | -14,004 | -5.88% | ✗ | $21.1K |
| May 25, 2021 | May 28, 2021 | Griffith Donald J. | Director | Sell | 27.5 | -4,235 | -4.24% | ✗ | $6.4K |
| May 25, 2021 | May 28, 2021 | Dexter Susan | Chief Technical Officer | Sell | 26.3 | -10,145 | -13.78% | ✗ | $15.3K |
| May 19, 2021 | May 20, 2021 | Kenney Richard T | Chief Medical Officer | Buy | 91.3 | +10,000 | 40.00% | ✗ | $15.5K |
| Mar 25, 2021 | Apr 1, 2021 | Kenney Richard T | Chief Medical Officer | Neutral | 90.0 | +25,000 | 100.00% | ✗ | - |
| Apr 1, 2021 | Kenney Richard T | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 2, 2020 | Jul 2, 2020 | Rao Raghu | Director | Neutral | 90.0 | +8,005 | 3758.22% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | RUGG TERENCE ANTHONY | Chief Medical Officer | Neutral | 90.0 | +21,314 | 100.00% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Mohan Pankaj | CEO | Neutral | 90.0 | +319,866 | 33.99% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Dexter Susan | Chief Technical Officer | Neutral | 90.0 | +73,613 | 100.00% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Cini John K. | Chief Scientific Officer | Neutral | 90.0 | +78,214 | 48.93% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Griffith Donald J. | Director | Neutral | 90.0 | +20,000 | 25.02% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Cross John Harry III | CFO | Neutral | 90.0 | +78,214 | 100.00% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Bhatt Nailesh | Director | Neutral | 90.0 | +8,005 | 150.24% | ✗ | - |
| Jul 2, 2020 | Jul 2, 2020 | Dyrness Albert D. | Director | Neutral | 90.0 | +8,005 | 161.20% | ✗ | - |
| Jun 10, 2020 | Jun 12, 2020 | Mohan Pankaj | CEO | Buy | 60.0 | +2,400 | 0.26% | ✗ | $9.8K |
| Jun 11, 2020 | Jun 12, 2020 | Dyrness Albert D. | Director | Buy | 90.0 | +2,409 | 94.21% | ✗ | $9.7K |
| Apr 1, 2020 | Jun 5, 2020 | Mohan Pankaj | CEO | Neutral | 90.0 | +930,705 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Rao Raghu | Director | Neutral | 90.0 | +213 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Mohan Pankaj | CEO | Neutral | 90.0 | +1,599,108 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Cini John K. | Chief Scientific Officer | Neutral | 90.0 | +159,857 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Griffith Donald J. | Director | Neutral | 90.0 | +79,928 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Bhatt Nailesh | Director | Neutral | 90.0 | +5,328 | 100.00% | ✗ | - |
| Apr 1, 2020 | Apr 3, 2020 | Dyrness Albert D. | Director | Neutral | 90.0 | +2,557 | 100.00% | ✗ | - |
| Apr 3, 2020 | Mohan Pankaj | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Cini John K. | Chief Scientific Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | RUGG TERENCE ANTHONY | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Dexter Susan | Chief Technical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Bhatt Nailesh | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Dyrness Albert D. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Griffith Donald J. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Rao Raghu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Apr 3, 2020 | Cross John Harry III | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Mar 23, 2020 | Mar 24, 2020 | Pruitt Michael D | CEO | Buy | 90.0 | +7,206 | 10.84% | ✗ | $4.1K |
| Mar 23, 2020 | Mar 24, 2020 | Glick Frederick L | President | Buy | 90.0 | +4,000 | 19.26% | ✗ | $2.5K |
| Feb 14, 2020 | Oz Rey LLC | 10% Owner | Neutral | 52.5 | - | 0.00% | ✗ | - |